Clinical Trial

Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease

Study acronym: ANDI-3
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn whether a camera pill examination of the whole bowel can be used to diagnose Crohn's disease instead of colonoscopy and a small bowel examination (either MRI or camera pill) in patients aged 18-40 years suspected of having Crohn's disease. The main question it aims to answer is: How many patients examined with a camera pill examination of the whole bowel will have a complete examination of the whole bowel and have a diagnosis made without need for any more examinations? Researchers will compare with patients examined with colonoscopy and a small bowel examination. Participants will: * Be examined with either a camera pill examination of the whole bowel, or a colonoscopy and a small bowel examination * Have their electronic medical records checked to see if a diagnosis has been made * Have an interview every three months if diagnosed with an inflammatory bowel disease or after a year if no disease was found
Trial Details
NCT Number NCT06882993
Lead Sponsor Esbjerg Hospital - University Hospital of Southern Denmark
Collaborators: Odense University Hospital, Svendborg Hospital, Skane University Hospital, Vejle Hospital
Conditions Crohn's Disease
Enrollment 165 participants
Start Date 2025-02-26
Primary Completion 2027-08-31 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-19